Innovate or Perish

EDWARD KAHN is founder and President of EKMS, Inc., an intellectual property management firm established in 1986 and based in Cambridge, Massachusetts. EKMS helps companies realize the full commercial value of their patents and technologies.? Edward's main areas of expertise are technology assessment and deal making. EKMS clients include the world's leading computer, automotive, aerospace life sciences, and chemical manufacturers such as Boeing, Pharmacia, DuPont, and IBM Corporation, as well as smaller corporations, universities, and individual inventors. He is frequently asked to write and comment on intellectual property topics in the business and trade press, and at conferences and forums around the country.

• ABOUT THE EDITOR ABOUT THE AUTHORS.PREFACE BY HENRY CHESBROUGH.Part 1:  PRINCIPLES OF GLOBAL LEADERSHIP IN THE ENDURING TECHNOLOGY COMPANY.1 THE POLYMATH CEO: ENLIGHTENED LEADERSHIP FOR THE ENDURING TECHNOLOGY COMPANY (EDWARD KAHN).PART 2: INTELLECTUAL PROPERTY MANAGEMENT.2 THE IP TOOLKIT: MAXIMIZING BUSINESS VALUE FROM INTELLECTUAL PROPERTY (EDMUND WALSH).3 HARVESTING NEW INTELLECTUAL ASSETS: THE ROLE OF BUSINESS METHOD PATENTS AND TRADE SECRETS IN STRATEGIC IP MANAGEMENT (KARL JORDA and WAYNE JAESCHKE).4 GIANTS CAN BE NIMBLE: THE SBC STORY (ABHA DIVINE).5 INNOVATION ASSET PORTFOLIO: THE INTELLECTUAL PROPERTY MUSE GETS AN MBA (DAMON MATTEO).PART 3: INNOVATION.6 INNOVATION STRATEGY: THE ESSENTIAL INGREDIENT (MICHAEL KAYAT).7 MAXIMIZING INNOVATION TEAMS: THE INTERNAL AND EXTERNAL CONNECTION NETWORK (CARSTEN WITTRUP).8 ROAD-MAPPING DISRUPTIVE TECHNICAL THREATS AND OPPORTUNITIES IN COMPLEX, TECHNOLOGY-BASED SUBSYSTEMS: THE SAILS METHODOLOGY (BRUCE VOJAK and FRANK CHAMBERS).PART 4: PARTNERED TECHNOLOGY AND BUSINESS DEVELOPMENT.9 OPEN FOR BUSINESS: THE AIR PRODUCTS AND CHEMICALS STORY (JOHN TAO and VINCENT MAGNOTTA).APPENDIX 9A: DETERMINING FAIR ROYALTY RATES FOR UNIVERSITY-DEVELOPED TECHNOLOGY EXCLUSIVE LICENSE OPTION.10 DEVELOPING GROWTH STRATEGIES USING INTELLECTUAL ASSETS AND STRATEGIC ALLIANCES (DENNIS McCULLOUGH).11 INNOVATION AND THE BIOPHARMACEUTICAL INDUSTRY: CRISIS OR CROSSROADS? (RONALD LINDSAY).12 BUILDING COMPANIES ON NOT-SO-FERTILE SOIL (TERI WILLEY).INDEX.